Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase - PubMed (original) (raw)
Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase
Randy Jacinto et al. J Immunol. 2002.
Abstract
Human Toll-like receptor (TLR) 4 and TLR2 receptors recognize LPS or lipoteichoic acid (LTA), respectively. Prolonged exposure of human macrophages/monocytes to bacterial LPS induces a state of adaptation/tolerance to subsequent LPS challenge. Inflammatory gene expressions such as IL-1beta and TNF-alpha are selectively repressed, while certain anti-inflammatory genes such as secretory IL-1R antagonist are still induced in LPS-adapted/tolerant cells. In this report, we demonstrate that LPS-tolerized human promonocytic THP-1 cells develop cross-tolerance and no longer respond to LTA-induced IL-1beta/TNF-alpha production, indicating that disruption of common intracellular signaling is responsible for the decreased IL-1beta/TNF-alpha production. We observe that down-regulation of IL-1R-associated kinase (IRAK) protein level and kinase activity closely correlates with the development of cross-tolerance. IRAK protein levels and kinase activities in LPS-tolerized cells remain low and hyporesponsive to subsequent LPS or LTA challenges. We also demonstrate that THP-1 cells with prolonged LTA treatment develop LTA tolerance and do not express IL-1beta/TNF-alpha upon further LTA challenge. Strikingly, cells tolerized with LTA are only refractory to subsequent LTA challenge and can still respond to LPS stimulation. Correspondingly, stimulation of TLR2 by LTA, although activating IRAK, does not cause IRAK degradation. IRAK from LTA-tolerized cells can be subsequently activated and degraded by further LPS challenge, but not LTA treatment. Our studies reveal that LTA-induced tolerance is distinct compared with that of LPS tolerance, and is likely due to disruption of unique TLR2 signaling components upstream of MyD88/IRAK.
Similar articles
- Distinct post-receptor alterations generate gene- and signal-selective adaptation and cross-adaptation of TLR4 and TLR2 in human leukocytes.
Li L, Jacinto R, Yoza B, McCall CE. Li L, et al. J Endotoxin Res. 2003;9(1):39-44. doi: 10.1179/096805103125001324. J Endotoxin Res. 2003. PMID: 12691617 - Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN. Medvedev AE, et al. J Immunol. 2002 Nov 1;169(9):5209-16. doi: 10.4049/jimmunol.169.9.5209. J Immunol. 2002. PMID: 12391239 - Enterococcus faecalis lipoteichoic acid suppresses Aggregatibacter actinomycetemcomitans lipopolysaccharide-induced IL-8 expression in human periodontal ligament cells.
Im J, Baik JE, Kim KW, Kang SS, Jeon JH, Park OJ, Kim HY, Kum KY, Yun CH, Han SH. Im J, et al. Int Immunol. 2015 Aug;27(8):381-91. doi: 10.1093/intimm/dxv016. Epub 2015 Apr 3. Int Immunol. 2015. PMID: 25840438 - Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation.
Li CH, Wang JH, Redmond HP. Li CH, et al. J Leukoc Biol. 2006 Apr;79(4):867-75. doi: 10.1189/jlb.0905505. Epub 2006 Feb 3. J Leukoc Biol. 2006. PMID: 16461741 - The recent advance of Interleukin-1 receptor associated kinase 4 inhibitors for the treatment of inflammation and related diseases.
Bai YR, Yang WG, Hou XH, Shen DD, Zhang SN, Li Y, Qiao YY, Wang SQ, Yuan S, Liu HM. Bai YR, et al. Eur J Med Chem. 2023 Oct 5;258:115606. doi: 10.1016/j.ejmech.2023.115606. Epub 2023 Jun 28. Eur J Med Chem. 2023. PMID: 37402343 Review.
Cited by
- Commensal microbiome dysbiosis elicits interleukin-8 signaling to drive fibrotic skin disease.
Zhang W, Peng Q, Huang X, Huang Q, Zhang Z, Li F, Zheng N, Shi B, Fan Z, Maj T, Chen R. Zhang W, et al. PNAS Nexus. 2024 Jul 30;3(7):pgae273. doi: 10.1093/pnasnexus/pgae273. eCollection 2024 Jul. PNAS Nexus. 2024. PMID: 39081787 Free PMC article. - Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives.
Tajbakhsh A, Yousefi F, Farahani N, Savardashtaki A, Reiner Ž, Jamialahmadi T, Sahebkar A. Tajbakhsh A, et al. Curr Med Chem. 2024;31(36):5898-5917. doi: 10.2174/0929867331666230727100123. Curr Med Chem. 2024. PMID: 37497711 Review. - Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts.
Tominari T, Sanada A, Ichimaru R, Matsumoto C, Hirata M, Itoh Y, Numabe Y, Miyaura C, Inada M. Tominari T, et al. Sci Rep. 2021 Jun 25;11(1):13353. doi: 10.1038/s41598-021-92744-5. Sci Rep. 2021. PMID: 34172796 Free PMC article. - Epigenetically regulated digital signaling defines epithelial innate immunity at the tissue level.
Clark HR, McKenney C, Livingston NM, Gershman A, Sajjan S, Chan IS, Ewald AJ, Timp W, Wu B, Singh A, Regot S. Clark HR, et al. Nat Commun. 2021 Mar 23;12(1):1836. doi: 10.1038/s41467-021-22070-x. Nat Commun. 2021. PMID: 33758175 Free PMC article. - Trained Innate Immunity and Its Implications for Mucosal Immunity and Inflammation.
Hajishengallis G, Li X, Mitroulis I, Chavakis T. Hajishengallis G, et al. Adv Exp Med Biol. 2019;1197:11-26. doi: 10.1007/978-3-030-28524-1_2. Adv Exp Med Biol. 2019. PMID: 31732931 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases